Rome, Italy

Gessica Filocamo


 

Average Co-Inventor Count = 4.5

ph-index = 1


Location History:

  • Rome, IT (2020)
  • Rome, IL (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gessica Filocamo: Pioneering Innovations in Biomedical Research

Introduction

Gessica Filocamo is an accomplished inventor based in Rome, Italy. With a strong focus on biomedical research, she has made significant contributions through her inventions, particularly in the field of monoclonal antibodies and therapeutic libraries. Currently, she holds two patents that exhibit her innovative spirit and commitment to advancing medical science.

Latest Patents

Filocamo's latest patents reflect her expertise in developing targeted therapies. One of her notable inventions is titled "Monoclonal antibody anti-FGFR4." This patent pertains to monoclonal antibodies that specifically bind to the acid box domain of FGFR4 and can be utilized as both medicaments and diagnostic agents. The scope of this patent includes nucleic acids coding for the antibody, vectors for its expression, and antibody-drug conjugates aimed at addressing colon cancer stem cells.

Her second patent, "HC-CDR3-only libraries with reduced combinatorial redundancy and optimized loop length distribution," presents a library of vectors comprising human HC-CDR3 regions. This innovative patent optimizes diversity with a focus on reducing redundancy for short HC-CDR3 loops while increasing coverage for longer loop lengths. The library is designed for selection against target antigens, emphasizing Filocamo's commitment to enhancing therapeutic options.

Career Highlights

Throughout her career, Gessica Filocamo has worked with prestigious companies such as Italfarmaco Spa and Exiris S.r.l. Her roles in these organizations have allowed her to apply her research in practical settings, directly contributing to advancements in biomedical technologies.

Collaborations

Filocamo has collaborated with several esteemed professionals in her field, notably including Armin Lahm and Christian Steinkuehler. These partnerships have played a crucial role in furthering her research initiatives and have helped in the successful development of her innovative projects.

Conclusion

Gessica Filocamo’s contributions to the field of biomedical research through her patents showcase her as a leading inventor in her domain. Her work on monoclonal antibodies and optimized therapeutic libraries not only highlights her innovative capabilities but also underscores her commitment to fighting diseases such as colon cancer. With her ongoing dedication to research and development, Filocamo is sure to continue making impactful advancements in the biomedical arena.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…